Predictors of Medication Adherence in Inflammatory Bowel Disease

BACKGROUND AND AIMS:This study reports cross-sectional medication adherence data from year 1 of the Manitoba Inflammatory Bowel Disease (IBD) Cohort Study, a longitudinal, population-based study of multiple determinants of health outcomes in IBD in those diagnosed within 7 yr.METHODS:A total of 326 participants completed a validated multi-item self-report measure of adherence, which assesses a range of adherence behaviors. Demographic, clinical, and psycho-social characteristics were also assessed by survey. Adherence was initially considered as a continuous variable and then categorized as high or low adherence for logistic regression analysis to determine predictors of adherence behavior.RESULTS:Using the cutoff score of 20/25 on the Medication Adherence Report Scale, high adherence was reported by 73% of men and 63% of women. For men, predictors of low adherence included diagnosis (UC: OR 4.42, 95% CI 1.66–11.75) and employment status (employed: OR 11.27, 95% CI 2.05–62.08). For women, predictors of low adherence included younger age (under 30 versus over 50 OR 3.64, 95% CI 1.41–9.43; under 30 vs. 40–49 yr: OR 2.62, 95% CI 1.07–6.42). High scores on the Obstacles to Medication Use Scale strongly related to low adherence for both men (OR 4.05, 95% CI 1.40–11.70) and women (OR 3.89, 95% CI 1.90–7.99). 5-ASA use (oral or rectal) was not related to adherence. For women, immunosuppressant use versus no use was associated with high adherence (OR 4.49, 95% CI 1.58–12.76). Low trait agreeableness was associated with low adherence (OR 2.03, 95% CI 1.12–3.66).CONCLUSIONS:Approximately one-third of IBD patients were low adherers. Predictors of adherence differed markedly between genders, although obstacles such as medication cost were relevant for both men and women.

[1]  Hayden B. Bosworth,et al.  Patient Treatment Adherence : Concepts, Interventions, and Measurement , 2008 .

[2]  L. Lix,et al.  The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  L. Aaronson,et al.  Symptom perception and adherence to asthma controller medications. , 2006, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[4]  C. Bernstein,et al.  Health care resource utilization in inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  J. George,et al.  Factors associated with medication nonadherence in patients with COPD: Chest 2005;128:3198–204 , 2006 .

[6]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[7]  A. Román,et al.  Adherence to treatment in inflammatory bowel disease. , 2005, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[8]  Theresa M. Marteau,et al.  Self-Reported Adherence to Cholesterol-Lowering Medication in Patients with Familial Hypercholesterolaemia: The Role of Illness Perceptions , 2004, Cardiovascular Drugs and Therapy.

[9]  M. Dimatteo.  Variations in Patients’ Adherence to Medical Recommendations: A Quantitative Review of 50 Years of Research , 2004, Medical care.

[10]  R. Moss‐Morris,et al.  Illness beliefs and adherence in diabetes mellitus: a comparison between Tongan and European patients. , 2004, The New Zealand medical journal.

[11]  A. Thomson.  Patient nonadherence to medication in inflammatory bowel disease. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[12]  M. J. Shale,et al.  Studies of compliance with delayed‐release mesalazine therapy in patients with inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[13]  S. Hanauer,et al.  Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. , 2003, The American journal of medicine.

[14]  G. Kephart,et al.  Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada , 2002, Journal of clinical pharmacy and therapeutics.

[15]  John Weinman,et al.  Self-regulation and Self-management in Asthma: Exploring The Role of Illness Perceptions and Treatment Beliefs in Explaining Non-adherence to Preventer Medication , 2002 .

[16]  S. Hanauer,et al.  Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis , 2001, American Journal of Gastroenterology.

[17]  R. Horne,et al.  Satisfaction with information and its relationship with adherence in patients with chronic pain , 2001 .

[18]  S. Grosso,et al.  Psychiatric Predictors of Noncompliance in Inflammatory Bowel Disease: Psychiatry and Compliance , 2001, Journal of clinical gastroenterology.

[19]  R Jenkins,et al.  The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research , 2001, Quality in health care : QHC.

[20]  H. Steinhart.  Maintenance therapy in Crohn's disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[21]  G. Greenberg,et al.  A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease , 2000 .

[22]  G. Greenberg,et al.  A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. , 2000, The New England journal of medicine.

[23]  P. Gard.  A behavioural approach to pharmacy practice , 2000 .

[24]  J. Weinman,et al.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.

[25]  D Johnson,et al.  The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. , 1999, AIDS.

[26]  A Wajda,et al.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.

[27]  M. Nichol,et al.  A Critical Evaluation of the Methodology of the Literature on Medication Compliance , 1999, The Annals of pharmacotherapy.

[28]  S. Kane.  Patient compliance and outcomes. , 1999, Inflammatory bowel diseases.

[29]  J. Weinman,et al.  The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .

[30]  Judith A. Hall,et al.  Effectiveness of interventions to improve patient compliance: a meta-analysis. , 1998, Medical care.

[31]  S. Morley,et al.  The Health Anxiety Questionnaire , 1996 .

[32]  R. R. Abidin.  Psychological Assessment Resources , 1995 .

[33]  M. Summers,et al.  Adherence to pharmacotherapeutic regimen. Assessment and intervention. , 1988, The Alabama journal of medical sciences.

[34]  Judee K. Burgoon,et al.  Relational communication, satisfaction, compliance-gaining strategies, and compliance in communication between physicians and patients , 1987 .

[35]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[36]  M. Lieberman,et al.  The stress process. , 1981, Journal of health and social behavior.

[37]  D. Sackett,et al.  Can Simple Clinical Measurements Detect Patient Noncompliance? , 1980, Hypertension.

[38]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[39]  L. Pearlin,et al.  The structure of coping. , 1978, Journal of health and social behavior.

[40]  J. Lennard-jones,et al.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. , 1978, Scandinavian journal of gastroenterology.